[Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000517:prevention & control; D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011446:Prospective Studies; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Thromboxyten-Funktionshemmer zur Prophylaxe der koronaren Herzkrankheit.